Modulation of the immune system by the gut microbiota in the development of type 1 diabetes

Human Vaccines & Immunotherapeutics
James A PearsonLi Wen

Abstract

T1D is an autoimmune disease characterized by T cell-mediated destruction of insulin-producing β-cells in the pancreatic islets of Langerhans, resulting in hyperglycemia, with patients requiring lifelong insulin treatment. Many studies have shown that genetics alone are not sufficient for the increase in T1D incidence and thus other factors have been suggested to modify the disease risk. T1D incidence has sharply increased in the developed world, especially amongst youth. In Europe, T1D incidence is increasing at an annual rate of 3-4%. Increasing evidence shows that gut microbiota, as one of the environmental factors influencing diabetes development, play an important role in development of T1D. Here, we summarize the current knowledge about the relationship between the microbiota and T1D. We also discuss the possibility of T1D prevention by changing the composition of gut microbiota.

References

Nov 1, 1992·Diabetes·C MathieuR Bouillon
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L GodfreyL B Russell
Nov 18, 1989·BMJ : British Medical Journal·D P Strachan
Jun 1, 1987·Annals of Internal Medicine·M E Conley, D L Delacroix
Jan 1, 1980·Jikken dobutsu. Experimental animals·S MakinoY Tochino
Aug 1, 1995·Diabetes Research and Clinical Practice·S ReddyR B Elliott
Aug 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·T MatsuzakiT Yokokura
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·W B WhitmanW J Wiebe
Feb 23, 2000·The Journal of Clinical Investigation·E LienD T Golenbock
Feb 24, 2001·Diabetologia·E A Gale, K M Gillespie
Apr 4, 2001·The Journal of Clinical Investigation·L WenF S Wong
Mar 26, 2002·Nature Immunology·Adeline M HajjarSamuel I Miller
Sep 20, 2002·The New England Journal of Medicine·Jean-Francois Bach
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Feb 20, 2003·The Journal of Experimental Medicine·Iris CaramalhoJocelyne Demengeot
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Terry K MeansAndrew D Luster
Jun 11, 2003·The Journal of Experimental Medicine·Yuichi HaradaKazumichi Kuroda
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susumu NakaeYoichiro Iwakura
Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Marian RewersEdward J Hoffenberg
Sep 18, 2004·European Journal of Immunology·Paola ZacconeAnne Cooke
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danny ZiprisAldo A Rossini
Jan 18, 2005·Nature Medicine·Karl S LangRolf M Zinkernagel
Jan 20, 2005·The Journal of Experimental Medicine·Claire L LangrishDaniel J Cua
Mar 18, 2005·Annual Review of Immunology·Mark S Anderson, Jeffrey A Bluestone
Jul 29, 2005·Immunological Reviews·Per Brandtzaeg, Finn-Eirik Johansen

❮ Previous
Next ❯

Citations

Jun 29, 2021·Frontiers in Immunology·James Alexander PearsonLi Wen

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
biopsy
PCR

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Cellular and Molecular Life Sciences : CMLS
Liana GhazarianAgnès Lehuen
Clinical Immunology : the Official Journal of the Clinical Immunology Society
Elke GüldenLi Wen
© 2022 Meta ULC. All rights reserved